U.S. Water Utilities Stock News

SLM (SLM) closed out FY 2025 with Q4 revenue of US$472.9 million and basic EPS of US$1.14, while trailing 12 month EPS sat at US$3.52 on revenue of about US$1.7 billion. The company has seen quarterly revenue move from US$281.8 million and EPS of US$0.51 in Q4 FY 2024 to US$472.9 million and EPS of US$1.14 in Q4 FY 2025, alongside trailing 12 month EPS shifting between US$2.73 and US$3.52 over the same window. For investors, the combination of higher trailing margins and these headline...

SouthState Bank (SSB) has wrapped up FY 2025 with fourth quarter revenue of US$680.3 million and basic EPS of US$2.48, while trailing twelve month revenue came in at about US$2.6 billion and EPS at US$7.90. Over the past year, the bank has seen revenue move from US$1.70 billion on a trailing basis in Q4 2024 to roughly US$2.6 billion by Q4 2025, with trailing EPS rising from US$7.01 to US$7.90 across the same period. This provides a backdrop for investors to weigh that earnings profile...

Old Republic International (ORI) closed out FY 2025 with fourth quarter revenue of US$2.4b, basic EPS of US$0.84 and net income of US$206.3m. The trailing twelve months show revenue of US$9.1b and EPS of US$3.82. Over the past year, revenue has moved from US$8.2b in the trailing period to Q4 2024 to US$9.1b in the latest trailing period, with EPS over those same trailing windows shifting from US$3.30 to US$3.82. For investors, the headline story is that Old Republic paired this top line and...

In recent months, Alarm.com Holdings reported weak billings growth and signaled only modest revenue expansion, raising questions about customer acquisition momentum and demand trends. Although the company has improved operating margins and profitability, these gains have not fully eased concerns about the resilience of its growth profile. With recent returns under pressure, we’ll explore how Alarm.com’s sluggish billings growth shapes its investment narrative and future prospects. This...

Parke Bancorp (PKBK) has just wrapped up FY 2025 with fourth quarter total revenue of US$22.2 million and basic EPS of US$0.95, capped by trailing twelve month revenue of US$77.4 million and EPS of US$3.20. Over recent periods the company has seen quarterly revenue move from US$16.6 million in Q4 2024 to US$22.2 million in Q4 2025, while basic EPS shifted from US$0.62 to US$0.95. This sets up a story where stronger recent profitability sits against a longer history of earnings pressure. See...

If you are wondering whether CVR Energy at around US$24.54 is offering good value or asking too much, you are exactly who this breakdown is for. The stock has returned 5.3% over the last 7 days, while the 1 year return sits at 18.6%, alongside a 6.9% decline over 30 days and a 2.6% decline year to date. These shifts can change how investors think about both growth potential and risk. Recent coverage of CVR Energy has focused on its role in the energy sector and how investor expectations are...

U.S. Physical Therapy (NYSE:USPH) is seeing rising competition that is weighing on profitability and returns on capital. Recent analysis points to shrinking returns on capital and higher capital intensity across its clinic network. These trends suggest the company is needing to commit more capital to sustain its position in the outpatient physical therapy market. For investors tracking NYSE:USPH, the share price sits at $85.7, with the stock up 6.8% over the past 30 days and 8.6% year to...

East West Bancorp (EWBC) has wrapped up FY 2025 with fourth quarter revenue of US$711.1 million and basic EPS of US$2.58, alongside net income of US$356.3 million, putting fresh numbers behind the story at a share price of US$111.35. Over the past year, revenue on a trailing twelve month basis has moved from US$2.39 billion in Q4 2024 to US$2.70 billion in Q4 2025. Over the same period, trailing EPS has gone from US$8.39 to US$9.58, giving investors a fuller picture of earnings power through...

If you are wondering whether Amplitude’s current share price really reflects what the business is worth, you are not alone. This article is built to unpack exactly that question in a clear, practical way. The stock closed at US$10.25, with a 3% gain over the last 7 days, but it is still showing a 14.2% decline over 30 days and a 9.9% decline over 1 year, with a 30.7% decline over 3 years and a 6.2% decline year to date. Recent news flow around Amplitude has focused on its position in product...

Earlier in January 2026, Guggenheim reaffirmed its positive view on Structure Therapeutics, pointing to increased confidence in its oral obesity drug aleniglipron and progress on the early-stage candidate ACCG-2671. Guggenheim also highlighted Structure Therapeutics’ licensing deal with Genentech, which includes a US$100,000,000 upfront payment and potential royalties, underscoring external validation of its pipeline. Next, we’ll examine how Guggenheim’s confidence in aleniglipron’s...

Wondering whether United Parks & Resorts at around US$37.49 is a bargain or a value trap right now? This article walks through what the current price might be telling you about the stock. The share price is up 5.3% over the last month and 3.5% year to date, but that sits against a 27.6% decline over the last year and a 40.2% decline over three years, which may have shifted how investors see both risk and potential reward. Recent coverage around United Parks & Resorts has highlighted the...

National Bankshares (NKSH) just wrapped up FY 2025 with fourth quarter total revenue of US$15.9 million and basic EPS of US$0.92, alongside net income of US$5.9 million. Trailing twelve month figures show revenue of US$55.6 million and EPS of US$2.49. Over the last few quarters, revenue has gone from US$12.3 million in Q4 2024 to US$15.9 million in Q4 2025, with basic EPS shifting from US$0.48 to US$0.92 across the same period. Trailing EPS moved from US$1.24 to US$2.49 as net profit margin...

Investar Holding (ISTR) has wrapped up FY 2025 with fourth quarter revenue of US$23.5 million and EPS of US$0.55, set against trailing twelve month revenue of US$93.6 million and EPS of US$2.22 that point to a solidly profitable year. The company has seen revenue move from US$86.3 million and EPS of US$2.06 on a trailing basis at the end of Q4 2024 to US$93.6 million and EPS of US$2.22 by Q4 2025, with net profit margin over the last year at 24.5% compared to 23.5% previously. With earnings...

iQIYI (IQ) is back on traders’ radar after the immediate resignation of long-time CFO Jun Wang, the appointment of interim finance head Ying Zeng, and new headlines on content performance and international viewership. See our latest analysis for iQIYI. The CFO change and strong content headlines have arrived after a mixed run for shareholders, with a 7 day share price return of 4.9% and a 1 month share price return of 7.1%, but a 1 year total shareholder return decline of 8.7% and a 5 year...

Bar Harbor Bankshares (BHB) just closed out FY 2025 with fourth quarter total revenue of US$48.2 million and basic EPS of US$0.70, supported by net income of US$11.8 million, while trailing twelve month figures show revenue of US$163.4 million and EPS of US$2.32. Over recent periods, quarterly revenue has moved from US$38.4 million in Q3 2024 to US$37.4 million in Q4 2024, then to US$37.3 million in Q1 2025 and US$44.0 million in Q3 2025 before reaching US$48.2 million in Q4 2025, as EPS...

Crinetics Pharmaceuticals has begun dosing pediatric patients in its Phase 2/3 BALANCE-CAH trial of atumelnant for classic congenital adrenal hyperplasia. Atumelnant is described as a first in class oral ACTH receptor antagonist and is currently the only small molecule in late stage development targeting this mechanism. The program received FDA Orphan Drug Designation for classic congenital adrenal hyperplasia, highlighting the focus on a rare pediatric condition with significant unmet...

BayCom (BCML) has wrapped up FY 2025 with fourth quarter total revenue of US$25.6 million and basic EPS of US$0.63, while trailing twelve month revenue came in at US$96.5 million with EPS of US$2.18. The company has seen revenue move from US$96.3 million and EPS of US$2.10 on a trailing basis at FY 2024 to the latest trailing totals of US$96.5 million and EPS of US$2.18. This sets the backdrop for investors to weigh consistent profitability against how margins might evolve from here. See our...

Heritage Commerce (HTBK) has just wrapped up FY 2025 with fourth quarter revenue of US$53.0 million and basic EPS of US$0.25, alongside trailing twelve month revenue of US$195.6 million and EPS of US$0.78 that reflect the latest run rate. The company has seen revenue move from US$170.3 million to US$195.6 million on a trailing basis, while EPS shifted from US$0.66 to US$0.78. This sets up a picture in which firmer earnings and slightly higher net profit margins are central to how investors...

South Atlantic Bancshares (SABK) has just wrapped up FY 2025 with fourth quarter total revenue of US$15.9 million and basic EPS of US$0.64, supported by net income of US$4.8 million. Over the past year, the company has seen total revenue move from US$13.4 million in Q4 2024 to US$15.9 million in Q4 2025, while trailing twelve month EPS stepped up from US$1.33 to US$2.15, setting the backdrop for reported earnings growth of 60.8% and a higher net profit margin of 26.9% versus 20.6% a year...

Webster Financial (WBS) has wrapped up FY 2025 with fourth quarter total revenue of US$704.2 million and basic EPS of US$1.62, capping a trailing twelve months in which revenue reached US$2.7 billion and EPS came in at US$5.98 alongside 32.5% year over year earnings growth. The company has seen quarterly revenue move from US$595.9 million in Q4 2024 to US$704.2 million in Q4 2025, while basic EPS stepped up from US$1.01 to US$1.62 over the same period. This sets the backdrop for investors to...

ACNB (ACNB) has wrapped up FY 2025 with fourth quarter revenue of US$36.6 million and EPS of US$1.04, supported by net income of US$10.8 million. Over the last few quarters, revenue has moved from US$26.6 million in Q4 2024 to US$41.3 million in Q3 2025 before landing at US$36.6 million in Q4 2025, while quarterly EPS has ranged from US$0.77 in Q4 2024 to US$1.43 in Q3 2025 and US$1.04 most recently, setting up a results season in which investors are weighing earnings power against the...

1st Source (SRCE) has just wrapped up FY 2025 with fourth quarter revenue of US$110.1 million and EPS of US$1.69, capping a trailing twelve month run of US$421.2 million in revenue and EPS of US$6.46. Over the past year, revenue has moved from US$374.7 million and EPS of US$5.36 on a trailing basis to US$421.2 million and EPS of US$6.46. Full year net income reached US$158.3 million. With margins now running at 37.6%, the latest numbers describe a bank that is monetizing its franchise...

National HealthCare (NHC) is back on investor radar after reporting 22.67% revenue growth, maintaining a "GREAT" financial health score and announcing a quarterly dividend of $0.64 per share. See our latest analysis for National HealthCare. That stronger backdrop has coincided with a 90 day share price return of 16.7% and a 1 year total shareholder return of 52.59%, suggesting momentum has been building around National HealthCare’s financial updates and dividend profile, even after a modest 1...

Kinder Morgan (KMI) just capped FY 2025 with Q4 revenue of US$4.5 billion and basic EPS of US$0.45, alongside net income of US$996 million, setting a clear marker for its latest reporting stretch. The company has seen quarterly revenue move from US$3.99 billion and EPS of US$0.30 in Q4 2024 to US$4.5 billion and EPS of US$0.45 in Q4 2025, with trailing twelve month EPS at US$1.37 and net income at US$3.1 billion providing a fuller earnings picture. With net profit margins highlighted as...